• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1

tetano

Editor, Senior Moderator
Cell Rep


. 2024 Aug 2;43(8):114567.
doi: 10.1016/j.celrep.2024.114567. Online ahead of print. Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1

Alexander Muik[SUP] 1 [/SUP], Jasmin Quandt[SUP] 1 [/SUP], Bonny Gaby Lui[SUP] 1 [/SUP], Maren Bacher[SUP] 1 [/SUP], Sebastian Lutz[SUP] 1 [/SUP], Maika Grünenthal[SUP] 1 [/SUP], Aras Toker[SUP] 1 [/SUP], Jessica Grosser[SUP] 1 [/SUP], Orkun Ozhelvaci[SUP] 1 [/SUP], Olga Blokhina[SUP] 1 [/SUP], Svetlana Shpyro[SUP] 1 [/SUP], Isabel Vogler[SUP] 1 [/SUP], Nadine Salisch[SUP] 1 [/SUP], Özlem Türeci[SUP] 2 [/SUP], Ugur Sahin[SUP] 3 [/SUP]



Affiliations
Free article Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure histories become increasingly complex through original and variant-adapted vaccines and infections with viral variants. Upon exposure to the highly altered Omicron spike glycoprotein, pre-immunized individuals predominantly mount recall responses of Wuhan-Hu-1 (wild-type)-imprinted memory B (B[SUB]MEM[/SUB]) cells mostly targeting conserved non-neutralizing epitopes, leading to diminished Omicron neutralization. We investigated the impact of imprinting in individuals double/triple vaccinated with a wild-type-strain-based mRNA vaccine who, thereafter, had two consecutive exposures to Omicron BA.1 spike (breakthrough infection followed by BA.1-adapted vaccine). We found that depletion of conserved epitope-recognizing antibodies using a wild-type spike bait results in strongly diminished BA.1 neutralization. Furthermore, spike-specific B[SUB]MEM[/SUB] cells recognizing conserved epitopes are much more prevalent than BA.1-specific B[SUB]MEM[/SUB] cells. Our observations suggest that imprinted B[SUB]MEM[/SUB] cell recall responses limit the induction of strain-specific responses even after two consecutive BA.1 spike exposures. Vaccine adaptation strategies need to consider that prior SARS-CoV-2 infections and vaccinations may cause persistent immune imprinting.

Keywords: BNT162b2; CP: Immunology; Omicron; SARS-CoV-2; breakthrough infection; immune imprinting; memory B cells; neutralizing antibody; original antigenic sin.

 
Back
Top Bottom